178 related articles for article (PubMed ID: 30250300)
1. Hypoxia-induced TUFT1 promotes the growth and metastasis of hepatocellular carcinoma by activating the Ca
Dou C; Zhou Z; Xu Q; Liu Z; Zeng Y; Wang Y; Li Q; Wang L; Yang W; Liu Q; Tu K
Oncogene; 2019 Feb; 38(8):1239-1255. PubMed ID: 30250300
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-induced cofilin 1 promotes hepatocellular carcinoma progression by regulating the PLD1/AKT pathway.
Yao B; Li Y; Chen T; Niu Y; Wang Y; Yang Y; Wei X; Liu Q; Tu K
Clin Transl Med; 2021 Mar; 11(3):e366. PubMed ID: 33784016
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-induced TRPM7 promotes glycolytic metabolism and progression in hepatocellular carcinoma.
Zhao F; Yu W; Hu J; Xia Y; Li Y; Liu S; Liu A; Wang C; Zhang H; Zhang L; Shi J
Eur J Pharmacol; 2024 Jul; 974():176601. PubMed ID: 38677534
[TBL] [Abstract][Full Text] [Related]
4. 14-3-3ζ up-regulates hypoxia-inducible factor-1α in hepatocellular carcinoma via activation of PI3K/Akt/NF-кB signal transduction pathway.
Tang Y; Lv P; Sun Z; Han L; Luo B; Zhou W
Int J Clin Exp Pathol; 2015; 8(12):15845-53. PubMed ID: 26884855
[TBL] [Abstract][Full Text] [Related]
5. The role and mechanism of HIF-1α-mediated glypican-3 secretion in hypoxia-induced tumor progression in hepatocellular carcinoma.
Wang P; Tong K; Li Y; Li X; Zhang Y; Gu J; Lei P; Yan S; Hu P
Cell Signal; 2024 Feb; 114():111007. PubMed ID: 38081444
[TBL] [Abstract][Full Text] [Related]
6. HIF-1α-activated TMEM237 promotes hepatocellular carcinoma progression via the NPHP1/Pyk2/ERK pathway.
Chen T; Wang L; Chen C; Li R; Zhu N; Liu R; Niu Y; Xiao Z; Liu H; Liu Q; Tu K
Cell Mol Life Sci; 2023 Apr; 80(5):120. PubMed ID: 37041420
[TBL] [Abstract][Full Text] [Related]
7. [Overexpression of tuftelin and KLF-5 and its clinicopathological features in hepatitis B virus-related hepatocellular carcinoma].
Yang JL; Fang RF; Xie Q; Tai BJ; Yao DF; Yao M
Zhonghua Gan Zang Bing Za Zhi; 2024 Feb; 32(2):148-154. PubMed ID: 38514264
[No Abstract] [Full Text] [Related]
8. The role of noncoding RNAs in the tumor microenvironment of hepatocellular carcinoma.
Yang Q; Tian H; Guo Z; Ma Z; Wang G
Acta Biochim Biophys Sin (Shanghai); 2023 Nov; 55(11):1697-1706. PubMed ID: 37867435
[TBL] [Abstract][Full Text] [Related]
9. GCNT3 Promotes Hepatocellular Carcinoma Progression and EMT by Activating the PI3K/AKT Pathway.
Wang Y; Fang X; Xie H; Wang X
Biochem Genet; 2024 May; ():. PubMed ID: 38789846
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-regulated target genes implicated in tumor metastasis.
Tsai YP; Wu KJ
J Biomed Sci; 2012 Dec; 19(1):102. PubMed ID: 23241400
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-Inducible Ubiquitin Specific Peptidase 13 Contributes to Tumor Growth and Metastasis via Enhancing the Toll-Like Receptor 4/Myeloid Differentiation Primary Response Gene 88/Nuclear Factor-κB Pathway in Hepatocellular Carcinoma.
Gao S; Chen T; Li L; Liu X; Liu Y; Zhao J; Lu Q; Zeng Z; Xu Q; Huang D; Tu K
Front Cell Dev Biol; 2020; 8():587389. PubMed ID: 33195243
[TBL] [Abstract][Full Text] [Related]
12. HHLA2 promotes hepatoma cell proliferation, migration, and invasion via SPP1/PI3K/AKT signaling pathway.
Wang J; Yang K; Yang X; Jin T; Tian Y; Dai C; Xu F
Mol Carcinog; 2024 Apr; ():. PubMed ID: 38578157
[TBL] [Abstract][Full Text] [Related]
13. TUFT1 is expressed in breast cancer and involved in cancer cell proliferation and survival.
Liu W; Zhang L; Jin Z; Zhao M; Li Z; Chen G; Sun L; Chen B
Oncotarget; 2017 Sep; 8(43):74962-74974. PubMed ID: 29088838
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-induced up-regulation of VASP promotes invasiveness and metastasis of hepatocellular carcinoma.
Liu Z; Wang Y; Dou C; Xu M; Sun L; Wang L; Yao B; Li Q; Yang W; Tu K; Liu Q
Theranostics; 2018; 8(17):4649-4663. PubMed ID: 30279729
[No Abstract] [Full Text] [Related]
15. Epithelial Mesenchymal and Endothelial Mesenchymal Transitions in Hepatocellular Carcinoma: A Review.
Gurzu S; Kobori L; Fodor D; Jung I
Biomed Res Int; 2019; 2019():2962580. PubMed ID: 31781608
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia regulates the mitochondrial activity of hepatocellular carcinoma cells through HIF/HEY1/PINK1 pathway.
Kung-Chun Chiu D; Pui-Wah Tse A; Law CT; Ming-Jing Xu I; Lee D; Chen M; Kit-Ho Lai R; Wai-Hin Yuen V; Wing-Sum Cheu J; Wai-Hung Ho D; Wong CM; Zhang H; Oi-Lin Ng I; Chak-Lui Wong C
Cell Death Dis; 2019 Dec; 10(12):934. PubMed ID: 31819034
[TBL] [Abstract][Full Text] [Related]
17. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
18. Inflammation and Liver Cancer: Molecular Mechanisms and Therapeutic Targets.
Yang YM; Kim SY; Seki E
Semin Liver Dis; 2019 Feb; 39(1):26-42. PubMed ID: 30809789
[TBL] [Abstract][Full Text] [Related]
19. EMT Transition States during Tumor Progression and Metastasis.
Pastushenko I; Blanpain C
Trends Cell Biol; 2019 Mar; 29(3):212-226. PubMed ID: 30594349
[TBL] [Abstract][Full Text] [Related]
20. Indian Hedgehog links obesity to development of hepatocellular carcinoma.
Chong YC; Lim TE; Fu Y; Shin EM; Tergaonkar V; Han W
Oncogene; 2019 Mar; 38(12):2206-2222. PubMed ID: 30470823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
